High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: Analysis of tumor recurrence - The University of Wisconsin experience

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 5, 1999, Pages 1267-1274

  Petereit, Daniel G ^a   Sarkaria, Jann N ^a   Potter, David M ^a   Schink, Julian C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cervical cancer; HDR brachytherapy; Radiation

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; SALPINGOOOPHORECTOMY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LINEAR MODELS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0032804166     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00262-X     Document Type: Article

References (31)

1. Stitt J.A., Fowler J.F., Thomadsen B.R., et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix The Madison System: I. Clinical and radiobiological considerations . Int J Radiat Oncol Biol Phys. 24:1992;383-386.
2. Thomadsen B.R., Shahabi S., Stitt J.A., et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix The Madison System: II. Procedural and physical considerations . Int J Radiat Oncol Biol Phys. 24:1992;349-357.
3. Petereit D.G., Fowler J.F., Kinsella T.J. Optimizing the dose rate and technique in cervical carcinoma - balancing cases versus complications. Int J Radiat Oncol Biol Phys. 29:1994;1195-1197.
4. Akine Y., Arimoto H., Ogino T., et al. High-dose-rate intracavitary irradiation in the treatment of carcinoma of the uterine cervix Early experience with 84 patients . Int J Radiat Oncol Biol Phys. 14:1988;893-898.
5. Arai T., Nakano T., Morita S., et al. High dose rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. Cancer. 69:1992;175-180.
6. Glaser F. Comparison of HDR afterloading with 192Ir versus conventional radium therapy in cervix cancer 5-year results and complications . Strahlenther Onkol. 82:(Suppl.):1988;106-113.
7. Hammer J., Zoidl J.P., Track C., et al. External beam and HDR intracavitary irradiation An effective tool in the primary treatment of cancer of the uterine cervix - excellent 10 year results and low side effects . Int J Radiat Oncol Biol Phys. 36:1996;317.
8. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., et al. Carcinoma of the cervix Analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy . Radiother Oncol. 42:1997;143-153.
9. Patel F.D., Sharma S.C., Neigi P.S., et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix A clinical trial . Int J Radiat Oncol Biol Phys. 28:1993;335-341.
10. Clark B.G., Souhami L., Evans M.D.C., et al. HDR Brachytherapy for cancer of cervix Technique and results . Activity. 8:1996;53-59.
11. Clark B.G., Souhami L., Roman T.N., et al. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 38:1997;989-993.
12. Rotte K. Comparison of HDR afterloading and classical radium techniques for radiation therapy of cancer of the cervix uteri. Act Select Brachyther. 2:(Suppl.):1991;42-46.
13. Teshima T., Inoue T., Ikeda H., et al. High-dose-rate and low-dose-rate intracavitary therapy for carcinoma of the uterine cervix. Cancer. 72:1993;2409-2414.
14. Vahrson G., Romer G. Five-year results with HDR afterloading in cervix cancer Dependence on fractionation and dose . Strahlenther Onkol. 82:(Suppl.):1988;139-146.
15. Sarkaria J.N., Petereit D.G., Hartmann T.J., et al. A comparison of the efficacy and complication rates of low dose rate versus high dose rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys. 30:1994;75-82.
16. Han I., Ezzell G.A., Orton C.G. HDR Brachytherapy for cancer of cervix Technique and results . Int Nucelotron Radiother J Activity. 8:1996;22-27.
17. Eifel P.J. High-dose-rate brachytherapy for carcinoma of the cervix High tech or high risk? Int J Radiat Oncol Biol Phys. 24:1992;383-386.
18. Petereit DG, Sarkaria JN, Schink JA; et al. Carcinoma of the uterine cervix: The University of Wisconsin experience. Proceedings from 8th International Brachytherapy Conference. Nice, France: Nucletron-Oldelft; 1995. Vol. 1, p. 92-96.
19. Klein J.P., Moeschberger M.L. Survival analysis Techniques for censored and truncated data . 1997;Springer, New York.
20. Fletcher G.H., Hamberger A.D. Squamous cell carcinoma of the uterine cervix Treatment technique according to size of the cervical lesion and extension . Fletcher G.H. Textbook of radiotherapy. 1980;720-778 Lea & Febiger, Philadelphia.
21. Eifel P.J., Logsdon M.D. FIGO Stage IIIB squamous cell carcinoma of the uterine cervix Natural history, treatment results, and prognostic factors . Int J Radiat Oncol Biol Phys. 36:(Suppl.):1996;217.
22. Lanciano R.M., Won M., Coia L., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix A final report of the 1973 and 1978 Patterns of Care Studies . Int J Radiat Oncol Biol Phys. 20:1991;667-676.
23. Gynecol Oncol. 66:1997;351-361.
24. Arthur D., Kaufam N., Schmidt-Ullrich R., et al. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 34:1995;743-751.
25. Petereit D.G., Sarkaria J.N., Chappell R., et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1301-1307.
26. Petereit D.G., Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 43:1999;359-366.
27. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 340:1999;1154-1161.
28. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153.
29. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143.
30. Whitney CW, Sause W, Bundy BN; et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol. In press.
31. Peters W.A., Liu P.Y., Barrett R.J., et al. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy Report of a phase III inter-group study . Gynecol Oncol. 72:1999;443.